Editorial Board
Editors in Chief
Paul Albert, PhD Professor and Senior Scientist, Ottawa Hospital Research Institute, Neuroscience University of Ottawa, Ottawa, Ont. P. Albert declares no potential conflicts of interest.
Ridha Joober, MD, PhD Director, PEPP-Montréal Senior Researcher, Douglas Mental Health University Institute Professor, Department of Psychiatry McGill University, Montréal, Que. R. Joober sits on the advisory boards and speakers' bureaus of Pfizer, Janssen Ortho, BMS, Sunovion, Otsuka, Lundbeck, Perdue and Myelin; he has received grant funding from them and from AstraZeneca and HLS. He has received honoraria from Janssen Canada, Shire, Lundbeck, Otsuka, Pfizer and Perdue for CME presentations and royalties from Henry Stewart talks.
Editor Emeritus
Yvon D. Lapierre, MD Y.D. Lapierre declares no potential conflicts of interest.
Associate Editors
Martin Alda, MD Professor of Psychiatry, Killam Chair in Mood Disorders Department of Psychiatry Dalhousie University, Halifax, NS M. Alda declares no potential conflicts of interest.
Isabelle Boileau, PhD Associate Professor, Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ont. I. Boileau declares no potential conflicts of interest.
Stephanie Borgland, PhD Professor of Physiology and Pharmacology Department of Psychiatry University of Calgary, Calgary AB S. Borgland declares no potential conflicts of interest.
M. Mallar Chakravarty, PhD Computational Neuroscientist, Cerebral Imaging Centre, Douglas Hospital Research Centre Assistant Professor, Department of Psychiatry, McGill University Montreal, Que. M.M. Chakravarty declares no potential conflicts of interest.
Cecilia Flores, PhD Professor, Department of Psychiatry, Douglas Research Centre, McGill University, Montreal, Que. C. Flores declares no potential conflicts of interest.
Marco Leyton, PhD Professor, William Dawson Scholar Department of Psychiatry, McGill University Center for Studies in Behavioral Neurobiology Department of Psychology, Concordia University Montréal, Que. M. Leyton declares no potential conflicts of interest.
Georg Northoff, MD, PhD Canada Research Chair in Mind, Brain Imaging and Neuroethics; ELJB-CIHR Michael Smith Chair in Neurosciences and Mental Health; and Research Unit Director, The Royal’s Institute of Mental Health Research, University of Ottawa, Ottawa, Ont. G. Northoff declares no potential conflicts of interest.
Lena Palaniyappan, MD, PhD Professor, Departments of Psychiatry, Medical Biophysics, Neuroscience, The Brain and Mind Institute, Western University, London, Ont. L. Palaniyappan reports personal fees from Janssen Canada, Otsuka Canada, SPMM Course Limited, UK, and the Canadian Psychiatric Association; book royalties from Oxford University Press; investigator-initiated educational grants from Sunovion, Janssen Canada and Otsuka Canada; and travel support from Boehringer Ingelheim and Magstim Limited.
Associate Editors (Statistics)
Norbert Schmitz, PhD Associate Professor Department of Psychiatry Associate Member Department of Epidemiology, Biostatistics & Occupational Health McGill University Douglas Mental Health University Institute Montréal, Que. N. Schmitz declares no potential conflicts of interest.
Aurelie Labbe, PhD Associate Professor, Centre de recherches mathématiques HEC Montréal, Montréal, Que. A. Labbe declares no potential conflicts of interest
Editorial Advisory Board
Galila Agam, PhD, Israel Clare Beasley, PhD, Canada Stefan Borgwardt, MD, PhD, Switzerland Jan Buitelaar, MD, PhD, Netherlands Udo Dannlowski, MD, PhD, Germany Stefan Ehrlich MD, PhD, Germany Stan Floresco, PhD, Canada Guido Frank, MD, USA Thomas S. Frodl, MD, Ireland Shigenobu Kanba, MD, PhD, Japan Matcheri Keshavan, MD, USA Naguib Mechawar, PhD, Canada Igor Nenadic, MD, Germany Patricia Ohrmann, MD, Germany Alessandro Serretti, MD, Italy Catherine Winstanley, PhD, Canada